AOD-9604
HGH fragment 176-191 studied for lipolytic and metabolic pathway research.
Testing & quality
Every batch is supplier-tested for identity and purity and randomly verified by independent third-party HPLC and mass spectrometry.
Compound classification
Synthetic fragment of human growth hormone (hGH 176-191) studied for metabolic effects.
Mechanism studied in the literature
Mimics the lipolytic C-terminal region of growth hormone without IGF-1-mediated effects. Studied in preclinical models for fat metabolism and energy expenditure.
Research areas
- Lipolysis and adipose tissue metabolism (preclinical)
- Growth hormone fragment pharmacology
- Metabolic pathway research
- Comparative fat-oxidation studies
Storage
Lyophilized: -20°C, protected from light. Reconstituted: 2-8°C, use within 28 days.
Reconstitution (laboratory)
Reconstitute with bacteriostatic or sterile water for injection (USP grade).
Related research peptides
Retatrutide
Triple agonist (GLP-1 / GIP / glucagon) studied for body composition and metabolic regulation research.
Tirzepatide
Dual GIP / GLP-1 receptor agonist studied for glycemic control and metabolic pathway research.
MOTS-c
Mitochondrial-derived peptide studied for insulin sensitivity, energy expenditure, and metabolic homeostasis.
SLU-PP-322
ERR agonist researched for exercise mimetic effects and mitochondrial biogenesis.